Article
The impact of genotype on age at loss of ambulation in individuals with Duchenne muscular dystrophy treated with corticosteroids: A single-center study of 555 patients.
Muscle & nerve - 1 Nov 2024
Zygmunt Alexander, Wong Brenda, Moon David, Horn Paul, Rathbun Richard, Lambert Joshua, Bange Jean, Rybalsky Irina, Reebals Lisa, Tian Cuixia
Abstract excerpt
INTRODUCTION/AIMS: Studies have demonstrated that certain genotypes in Duchenne muscular dystrophy (DMD) have milder or more severe phenotypes. These studies included individuals treated and not treated with corticosteroids and multiple sites with potentially varying standards of care. We aimed to assess genotype-phenotype correlations for age at loss of ambulation (LoA) in a large cohort of individuals with DMD...
Topics
- Humans
- Muscular Dystrophy, Duchenne
- Male
- Child
- Retrospective Studies
- Adolescent
- Genotype
- Child, Preschool
- Adrenal Cortex Hormones
- Young Adult
